Understanding prostate cancer differences between African American and European American men
Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men
This study is looking at how prostate cancer affects African American and European American men differently by creating special cell models, which could help us understand why African American men have higher rates of this cancer and find better ways to prevent and treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11079446 on NIH RePORTER |
What this research studies
This research investigates the biological differences in prostate cancer between African American (AA) and European American (EA) men by developing functional human cell models. The study utilizes a technique called Conditional Reprogramming (CR) to create cell cultures from normal and cancerous prostate tissues, allowing researchers to explore how these cells behave and differ in their response to cancer. By examining these differences, the research aims to uncover the underlying reasons for the higher incidence and mortality rates of prostate cancer in AA men compared to EA men. This could lead to more effective prevention and treatment strategies tailored to these populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include African American and European American men diagnosed with prostate cancer or at risk of developing it.
Not a fit: Patients with prostate cancer who are not of African American or European American descent may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for prostate cancer, particularly for African American men who are disproportionately affected.
How similar studies have performed: Previous research using Conditional Reprogramming technology has shown promise in developing human cancer models, indicating potential for success in this novel approach.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Liu, Xuefeng — Ohio State University
- Study coordinator: Liu, Xuefeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.